Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lohmander

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Factors Underlying Patient and Surgeon Willingness to Participate in a Placebo Surgery Controlled trial: A Qualitative InvestigationSamantha Bunzli, Elizabeth Nelson, Laura Wall, et al.
Frontiers in Surgery|March 6, 2020
The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to ActionCade Shadbolt, J Haxby Abbott, Ximena Camacho, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiativeA V Perruccio, L Stefan Lohmander, M Canizares, et al.
British Journal of Sports Medicine|September 6, 2019
Three steps to changing the narrative about knee osteoarthritis care: a call to actionJ P Caneiro, Peter B O'Sullivan, Ewa M Roos, et al.
Osteoarthritis and Cartilage|March 4, 2024
Timing is everything: Towards classification criteria for early-stage symptomatic knee osteoarthritisArmaghan Mahmoudian, Lauren K King, Jean W Liew, et al.
The Journal of Rheumatology|March 9, 2007
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trialsWalter P Maksymowych, Robert Landewe, Maarten Boers, et al.
Annals of Surgery|December 22, 2020
Placebo Surgery Controlled Trials: Do They Achieve What They Set Out To Do? A Systematic ReviewSamantha Bunzli, Emma Choong, Cade Shadbolt, et al.
BMC Musculoskeletal Disorders|February 12, 2009
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centresPaul Dieppe, Andrew Judge, Susan Williams, et al.
Osteoarthritis and Cartilage|May 24, 2023
A scoping review of how early-stage knee osteoarthritis has been definedJean W Liew, Lauren K King, Armaghan Mahmoudian, et al.
Arthritis Care & Research|November 6, 2014
Effect of weight maintenance on symptoms of knee osteoarthritis in obese patients: a twelve-month randomized controlled trialRobin Christensen, Marius Henriksen, Anthony R Leeds, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Factors Underlying Patient and Surgeon Willingness to Participate in a Placebo Surgery Controlled trial: A Qualitative InvestigationSamantha Bunzli, Elizabeth Nelson, Laura Wall, et al.
Frontiers in Surgery|March 6, 2020
The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to ActionCade Shadbolt, J Haxby Abbott, Ximena Camacho, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiativeA V Perruccio, L Stefan Lohmander, M Canizares, et al.
British Journal of Sports Medicine|September 6, 2019
Three steps to changing the narrative about knee osteoarthritis care: a call to actionJ P Caneiro, Peter B O'Sullivan, Ewa M Roos, et al.
Osteoarthritis and Cartilage|March 4, 2024
Timing is everything: Towards classification criteria for early-stage symptomatic knee osteoarthritisArmaghan Mahmoudian, Lauren K King, Jean W Liew, et al.
The Journal of Rheumatology|March 9, 2007
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trialsWalter P Maksymowych, Robert Landewe, Maarten Boers, et al.
Annals of Surgery|December 22, 2020
Placebo Surgery Controlled Trials: Do They Achieve What They Set Out To Do? A Systematic ReviewSamantha Bunzli, Emma Choong, Cade Shadbolt, et al.
BMC Musculoskeletal Disorders|February 12, 2009
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centresPaul Dieppe, Andrew Judge, Susan Williams, et al.
Osteoarthritis and Cartilage|May 24, 2023
A scoping review of how early-stage knee osteoarthritis has been definedJean W Liew, Lauren K King, Armaghan Mahmoudian, et al.
Arthritis Care & Research|November 6, 2014
Effect of weight maintenance on symptoms of knee osteoarthritis in obese patients: a twelve-month randomized controlled trialRobin Christensen, Marius Henriksen, Anthony R Leeds, et al.
Pageof 20